WASHINGTON & TELTOW, Germany--(BUSINESS WIRE)--SensoMotoric Instruments (SMI), a leading global manufacturer of eye and gaze tracking solutions, today announced that RightEye LLC has included SMI remote eye trackers as a component of its revolutionary new vision tests that help healthcare providers assess concussions, eye sight, and medical and performance issues in patients. The new SMI RED-oem technology is part of SMI’s mass-market-ready eye tracking platform, which is ready to be picked up by industrial and consumer technology OEMs.
‟The successful launch of RightEye's first series of vision tests is critical to our future success and our ability to change the way the world approaches vision care,” said Adam Gross, co-founder and CEO of RightEye LLC. ‟We have included SMI in our first product series because they can deliver the exact kind of high-speed, high-quality and contact-free eye tracker required to ensure our solution is highly accurate and meets the needs of health care providers and their patients.”
RightEye, a health technology company using eye tracking to revolutionize vision performance and patient care, launched RightEye Neuro Vision this past September at the 2015 American Academy of Optometry show. In just the first two months since its product launch, RightEye has earned significant praise and interest from leading vision care and concussion experts across the U.S. as well as the health tech investor community.
‟As a leading eye tracking partner, we work with a wide variety of technology innovators, from startups like RightEye to many of the largest leading consumer technology manufacturers around the world,” said Christian Villwock, director of SMI’s OEM Solutions Business. ‟We are absolutely dedicated to advancing the use and integration of eye tracking into solutions and products that can help improve lives and open up new discoveries. We are excited to be working with RightEye and look forward to what they will come up with next.”
SMI RED-oem technology for contact-free, screen-based eye tracking is fully portable and comes with a large headbox for robust tracking even with restless participants. It is a component of SMI’s complete mass-market-ready eye tracking platform which contains reference designs for desktop, mobile and wearable virtual reality and augmented reality. SMI has more than two decades of experience with OEMs and globally renowned research institutes, and its eye tracking technology has been used by more than 5 million users under the broadest range of conditions. This is complemented by a track record of more than 20 successful eye tracking integrations into commercial OEM devices.
About SensoMotoric Instruments (SMI)
SensoMotoric Instruments is a world leader in eye tracking technology, developing and marketing eye and gaze tracking solutions for scientists and professionals, as well as OEM and medical solutions for a wide range of applications. Find out more at www.smivision.com or follow us on Facebook, Flickr, YouTube and Twitter.
RightEye LLC is a health technology company using eye tracking to revolutionize vision performance and patient care. By following a science-based, metric-driven methodology, RightEye can help you improve how you see, how you feel and how you perform. In less than two minutes, RightEye’s patented technology measures visual skills and provides critical insights into your health. RightEye’s first revolutionary vision test — RightEye Neuro Vision — is a first-of-its-kind, 15-second concussion detection tool. At CES 2016, RightEye will be unveiling RightEye Essential Vision, which is a two-minute, comprehensive vision test that is expected to one day replace the standard vision screenings used in schools and doctors’ offices around the world. Come visit us at CES at the Digital Health Summit at the Sands in Booth No. 73944 and see what the future of vision care looks like. For more information, visit www.RightEye.com or follow us on Twitter or LinkedIn.